RLMD
Relmada Therapeutics, Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2025-12-15 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $4.10 to $4.12 per share, inclusive. |
Common Stock
|
27,500 |
| 2025-12-15 | Shenouda Maged |
Chief Financial Officer |
Buy↑
|
Common Stock
|
11,665 |
| 2025-12-12 | CASAMENTO CHARLES J |
Director |
Award↑
Filing footnotes — Stock Appreciation Rights (Direct)
The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026. |
Stock Appreciation Rights
|
164,000 |
| 2025-12-12 | Fedeli Fabiana |
Director |
Award↑
Filing footnotes — Stock Appreciation Rights (Direct)
The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026. |
Stock Appreciation Rights
|
164,000 |
| 2025-12-12 | GLASSPOOL JOHN |
Director |
Award↑
Filing footnotes — Stock Appreciation Rights (Direct)
The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026. |
Stock Appreciation Rights
|
164,000 |
| 2025-12-12 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Appreciation Rights (Direct)
The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026. |
Stock Appreciation Rights
|
1,198,000 |
| 2025-12-12 | Ence Chuck |
CA and CO |
Award↑
Filing footnotes — Stock Appreciation Rights (Direct)
The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026. |
Stock Appreciation Rights
|
828,000 |
| 2025-12-12 | Shenouda Maged |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Appreciation Rights (Direct)
The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026. |
Stock Appreciation Rights
|
828,000 |
| 2025-12-12 | Kelly Paul Edward |
Director, COO |
Award↑
Filing footnotes — Stock Appreciation Rights (Direct)
The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026. |
Stock Appreciation Rights
|
828,000 |
| 2025-11-05 | Shenouda Maged |
Chief Financial Officer |
Buy↑
|
Common Stock
|
500,000 |
| 2025-11-05 | Ence Chuck |
CA and CO |
Buy↑
|
Common Stock
|
136,000 |
| 2025-11-05 | Kelly Paul Edward |
Director, COO |
Buy↑
|
Common Stock
|
90,000 |
| 2025-11-05 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
272,500 |
| 2025-08-28 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.68 to $0.79 per share, inclusive. |
Common Stock
|
55,976 |
| 2025-08-27 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.65 to $0.69 per share, inclusive. |
Common Stock
|
129,455 |
| 2025-08-26 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.61 to $0.65 per share, inclusive. |
Common Stock
|
80,545 |
| 2025-06-26 | GLASSPOOL JOHN |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest in 16 equal quarterly installments commencing on September 26, 2025. |
Stock Option (right to buy)
|
100,000 |
| 2025-06-26 | CASAMENTO CHARLES J |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest in 16 equal quarterly installments commencing on September 26, 2025. |
Stock Option (right to buy)
|
100,000 |
| 2025-06-26 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest in 16 equal quarterly installments commencing on September 26, 2025. |
Stock Option (right to buy)
|
800,000 |
| 2025-06-26 | Fedeli Fabiana |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest in 16 equal quarterly installments commencing on September 26, 2025. |
Stock Option (right to buy)
|
100,000 |
| 2025-06-26 | Ence Chuck |
CA and CO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest in 16 equal quarterly installments commencing on September 26, 2025. |
Stock Option (right to buy)
|
400,000 |
| 2025-06-26 | Kelly Paul Edward |
Director, COO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest in 16 equal quarterly installments commencing on September 26, 2025. |
Stock Option (right to buy)
|
400,000 |
| 2025-06-26 | Shenouda Maged |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest in 16 equal quarterly installments commencing on September 26, 2025. |
Stock Option (right to buy)
|
600,000 |
| 2025-05-20 | Shenouda Maged |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.4998 to $0.5396 per share, inclusive. |
Common Stock
|
60,000 |
| 2025-05-20 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.53 to $0.59 per share, inclusive. |
Common Stock
|
147,686 |
| 2025-05-19 | Shenouda Maged |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.4493 to $0.4998 per share, inclusive. |
Common Stock
|
90,000 |
| 2025-05-19 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.4998 to $0.50 per share, inclusive. |
Common Stock
|
30,000 |
| 2025-05-16 | Shenouda Maged |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.4229 to $0.4674 per share, inclusive. |
Common Stock
|
50,000 |
| 2025-05-16 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.4485 to $0.4564 per share, inclusive. |
Common Stock
|
172,314 |
| 2025-05-16 | Ence Chuck |
CA and CO |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.401 to $0.4892 per share, inclusive. |
Common Stock
|
228,961 |
| 2025-05-16 | Kelly Paul Edward |
Director, COO |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $0.4071 to $0.4498 per share, inclusive. |
Common Stock
|
200,000 |
| 2024-10-22 | CASAMENTO CHARLES J |
Director |
Gift↓
|
Common Stock
|
13,000 |
| 2024-09-11 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $2.84 to $3.05 per share, inclusive. |
Common Stock
|
51,407 |
| 2024-09-11 | Shenouda Maged |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $2.79 to $3.05 per share, inclusive. |
Common Stock
|
24,120 |
| 2024-09-10 | Shenouda Maged |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $2.70 to $2.75 per share, inclusive. |
Common Stock
|
21,118 |
| 2024-09-10 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $2.73 to $2.80 per share, inclusive. |
Common Stock
|
33,014 |
| 2024-09-09 | Shenouda Maged |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $2.49 to $2.60 per share, inclusive. |
Common Stock
|
8,194 |
| 2024-09-09 | CASAMENTO CHARLES J |
Director |
Buy↑
|
Common Stock
|
13,000 |
| 2024-09-09 | Kelly Paul Edward |
Director, COO |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $2.50 to $2.64 per share, inclusive. |
Common Stock
|
25,000 |
| 2024-09-09 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. Purchase prices range from $2.51 to $2.85 per share, inclusive. |
Common Stock
|
55,579 |
| 2024-05-24 | Kelly Paul Edward |
Director, COO |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer. |
Stock Option (right to buy)
|
43,700 |
| 2024-05-24 | Kelly Paul Edward |
Director, COO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 43,700 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. |
Stock Option (right to buy)
|
43,700 |
| 2024-05-24 | Ence Chuck |
CA and CO |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 54,624 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. |
Stock Option (right to buy)
|
54,624 |
| 2024-05-24 | GLASSPOOL JOHN |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 20,976 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. |
Stock Option (right to buy)
|
20,976 |
| 2024-05-24 | CASAMENTO CHARLES J |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 20,976 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. |
Stock Option (right to buy)
|
20,976 |
| 2024-05-24 | Ence Chuck |
CA and CO |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer. |
Stock Option (right to buy)
|
54,624 |
| 2024-05-24 | Fedeli Fabiana |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 20,976 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. |
Stock Option (right to buy)
|
20,976 |
| 2024-05-24 | Shenouda Maged |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, under the terms of the option award granted to the Reporting Person on December 15, 2023 (the "December Award"), the Reporting Person became entitled to receive options for up to 54,624 additional shares of the Issuer's Common Stock on the same terms as the December Award (the "Additional Award Shares") out of shares that had become available under the terms of the Issuer's 2021 Equity Incentive Plan, as amended (the "Plan"), since December 15, 2023, as a result of expirations, cancelations, forfeitures and terminations of other outstanding awards under the Plan and/or tenders or withholding of shares. |
Stock Option (right to buy)
|
54,624 |
| 2024-05-24 | Shenouda Maged |
Chief Financial Officer |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer. |
Stock Option (right to buy)
|
54,624 |
| 2024-05-24 | TRAVERSA SERGIO |
Director, Chief Executive Officer |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On May 24, 2024, the Reporting Person voluntarily forfeited to the Issuer a portion of the December Award equal to the Additional Award Shares so that those shares can be allocated to the holders of Similar Awards who are not executive officers or directors of the Issuer. |
Stock Option (right to buy)
|
122,358 |